Dissecting the mode of action of various HIV-inhibitor classes in a stable cellular system

被引:31
作者
Klimkait, T [1 ]
Stauffer, F [1 ]
Lupo, E [1 ]
Sonderegger-Rubli, C [1 ]
机构
[1] Novartis Pharma Inc, Basel, Switzerland
关键词
D O I
10.1007/s007050050447
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We describe a stable and sensitive HN evaluation system, which discriminates HIV-specific membrane fusion and early transcription events and is suitable for high-throughput inhibitor screening. A human lymphocytic line, constitutively producing infectious HIV-1, serves as Env-positive donor. A second indicator cell line carries a silent HIV-1 LTR lacZ reporter plasmid. A bicellular cocultivation setup allows titration and standardization of "fusion-induced gene stimulation (FIGS)" events. With few manipulations aspects of fusion and/or LTR induction can be distinguished and simultaneously assayed. Anti-Env-VS antibodies prevent fusion and subsequent lacZ induction, and a Tat-specific inhibitor blocks only lacZ induction in a dose dependent manner without affecting membrane fusion. The LTR reporter is readily activated by Tat from HIV-1, HIV-2, or SIV and it responds to exogenous Tat protein. The reporter system is sensitive enough to detect single infection events on pre-seeded layers of indicator cells, which renders it potentially useful for direct virus quantification in patients' material. Moreover, our system allows to control and normalize DNA transfection efficiencies of HIV-derived plasmids. This aspect is particularly valuable for studies of RT- and protease-inhibitors and resistances, where p24 or supernatant reverse transcriptase, otherwise standard virus readouts, can be directly affected by inhibitors or mutations.
引用
收藏
页码:2109 / 2131
页数:23
相关论文
共 41 条
[11]   A BIOASSAY FOR HIV-1 BASED ON ENV-CD4 INTERACTION [J].
CIMINALE, V ;
FELBER, BK ;
CAMPBELL, M ;
PAVLAKIS, GN .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (11) :1281-1287
[12]   FUSION FROM WITHOUT DIRECTED BY HUMAN-IMMUNODEFICIENCY-VIRUS PARTICLES [J].
CLAVEL, F ;
CHARNEAU, P .
JOURNAL OF VIROLOGY, 1994, 68 (02) :1179-1185
[13]   PERTURBATION OF THE CARBOXY-TERMINUS OF HIV-1 REV AFFECTS MULTIMERIZATION ON THE REV RESPONSIVE ELEMENT [J].
DALY, TJ ;
RENNERT, P ;
LYNCH, P ;
BARRY, JK ;
DUNDAS, M ;
RUSCHE, JR ;
DOTEN, RC ;
AUER, M ;
FARRINGTON, GK .
BIOCHEMISTRY, 1993, 32 (34) :8945-8954
[14]   THE SPECIFICITY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 TRANSACTIVATOR IS DIFFERENT FROM THAT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
EMERMAN, M ;
GUYADER, M ;
MONTAGNIER, L ;
BALTIMORE, D ;
MUESING, MA .
EMBO JOURNAL, 1987, 6 (12) :3755-3760
[15]   A SYNCYTIA ASSAY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE-I (HIV-I) ENVELOPE PROTEIN AND ITS USE IN STUDYING HIV-I MUTATIONS [J].
FELSER, JM ;
KLIMKAIT, T ;
SILVER, J .
VIROLOGY, 1989, 170 (02) :566-570
[16]   IDENTIFICATION OF CELLULAR PROTEINS THAT BIND TO THE HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 TRANS-ACTIVATION-RESPONSIVE TAR ELEMENT RNA [J].
GATIGNOL, A ;
KUMAR, A ;
RABSON, A ;
JEANG, KT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (20) :7828-7832
[17]  
GAZDAR AF, 1980, BLOOD, V55, P409
[18]   BIOASSAY FOR TRANS-ACTIVATION USING PURIFIED HUMAN IMMUNODEFICIENCY VIRUS TAT-ENCODED PROTEIN - TRANS-ACTIVATION REQUIRES MESSENGER-RNA SYNTHESIS [J].
GENTZ, R ;
CHEN, CH ;
ROSEN, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (03) :821-824
[19]   TRANSFORMATION OF RAT CELLS BY DNA OF HUMAN ADENOVIRUS-5 [J].
GRAHAM, FL ;
VANDEREB, AJ .
VIROLOGY, 1973, 54 (02) :536-539
[20]   A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition [J].
Hamy, F ;
Brondani, V ;
Flörsheimer, A ;
Stark, W ;
Blommers, MJJ ;
Klimkait, T .
BIOCHEMISTRY, 1998, 37 (15) :5086-5095